An RNA polymerase II elongation factor encoded by the human ELL gene

Science

Volumn 271, Issue 5257, 1996, Pages 1873-1876

  Shilatifard, Ali ^a   Lane, William S ^b   Jackson, Kenneth W ^c   Conaway, Ronald C ^a   Conaway, Joan W ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; RNA POLYMERASE II;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CHROMOSOME 11; CHROMOSOME 19; CONTROLLED STUDY; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0029879664     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.271.5257.1873     Document Type: Article

References (27)

1. E. Solomon, J Borrow, A. D. Goddard, Science 254, 1153 (1991); M. L. Cleary, Cell 66, 619 (1991).
2. E. Solomon, J Borrow, A. D. Goddard, Science 254, 1153 (1991); M. L. Cleary, Cell 66, 619 (1991).
3. T. H. Rabbitts, Nature 372, 143 (1994).
4. M. J. Thirman, D. A Levitan, H. Kobayashi, M. C. Simon, J. D. Rowley, Proc. Natl. Acad Sci. U.S.A. 91, 12110 (1994), K. Mitani et al., Blood 85, 2017 (1995).
5. M. J. Thirman, D. A Levitan, H. Kobayashi, M. C. Simon, J. D. Rowley, Proc. Natl. Acad Sci. U.S.A. 91, 12110 (1994), K. Mitani et al., Blood 85, 2017 (1995).
6. D. C. Tkachuk, S. Kohler, M. L. Cleary, Cell 71, 691 (1992).
7. Y. Gu et al, ibid., p. 701.
8. 4, were pooled, dialyzed against buffer B to a conductivity equivalent to that of buffer B containing 0.07 M KCl, and applied to a TSK DEAE-NPR (35 mm by 4 6 mm; Toso-Haas, Montgomeryville, PA) equilibrated in the same buffer. The column was eluted at 0 3 ml/min with a linear gradient from 0.07 to 0.5 M KCl in buffer B Fractions (0.1 ml) were collected, and the active fractions, which eluted with ∼0.2 M KCl, were pooled, diluted with an equal volume of 4 M guanidine hydrochlonde, 4 M urea, 7.5% acetonitrile, O 15% trifluoroacetic acid (TFA), and O 2% Zwittergent ZC-8 (Calbiochem, La Jolla, CA), and applied at 0 1 ml/min to a PLRP-S(1 mm by 50 mm; pore size 1000 Å, particle size 8 μm) rpHPLC column (Michrom BioResources, Auburn, CA) preequilibrated at 40°C in 2% eluant B (90% acetonitrile, 0.09% TFA) and 98% eluant A (2% acetonitrile, 0.1% TFA). The column was developed at 0 1 ml/min with a 2-min linear gradient from 2 to 25% eluant B, followed by a 23-min linear gradient from 25 to 60% eluant B.
9. G. A. Rice, C. M. Kane, M J. Chamberlin, Proc. Natl, Acad. Sci. U.S.A. 88, 4245 (1991).
10. 32P]CTP (400 Ci/mmol, Amersham). Transcripts were analyzed by electrophoresis through a 6% polyacrylamide, 7 0 M urea gel
11. Approximately 50 pmol of PLRP-S-punfied rat p80 (6) was reduced, S-carboxyamidomethylated. digested with trypsin, and fractionated by microbore HPLC. Optimal peptides were determined by differential absorbance of ultraviolet light and matrix assisted laser de sorption mass spectrometry (Lasermat; Finnigan-MAT, San Jose, CA). The peptides were then sequenced by automated Edman degradation [W S Lane, A. Galat, M. W. Harding, S. L Schreiber, J. Protein Chem 10, 151 (1991)].
12. 4. 1 mM DTT, and 10% (v/v) glycerol After 90 min on ice, the protein was dialyzed for 3 hours at 4°C against the same buffer without DTT
13. A. Shilatifard, R C. Conaway, J. W. Conaway, unpublished data.
14. P. H. Domer et al., Proc Natl. Acad. Sci U S.A. 90, 7884 (1993).
15. T. Nakamura et al., ibid., p. 4631.
16. R. Prasad et al., Cancer Res. 53, 5624 (1993).
17. O. A. Bernard, M. Mauchauffe, C. Mecucci, H. Van Den Berghe, R. Berger, Oncogene 9, 1039 (1994).
18. J Corral et al., Proc. Natl. Acad. Sci. U.S A. 90, 8538 (1993).
19. T. Aso, J. W. Conaway, R. C. Conaway, FASEB J. 9, 1419 (1995).
20. N F. Marshall and D H. Price, J Biol Cbem. 270, 12335 (1995).
21. D R Duan et al , Science 269, 1402 (1995); T. Aso, W. S. Lane, J W. Conaway, R. C Conaway, ibid., p 1439, A Kibel, O. lliopoulos, J. A. DeCaprio, W. G Kaelin Jr, ibid., p. 1444.
22. D R Duan et al , Science 269, 1402 (1995); T. Aso, W. S. Lane, J W. Conaway, R. C Conaway, ibid., p 1439, A Kibel, O. lliopoulos, J. A. DeCaprio, W. G Kaelin Jr, ibid., p. 1444.
23. D R Duan et al , Science 269, 1402 (1995); T. Aso, W. S. Lane, J W. Conaway, R. C Conaway, ibid., p 1439, A Kibel, O. lliopoulos, J. A. DeCaprio, W. G Kaelin Jr, ibid., p. 1444.
24. S. Tan, R. C. Conaway, J W. Conaway, Biotechniques 16, 824 (1994).
25. K P. Garrett et al., Proc. Natl. Acad. Sci. U.S A 91, 5237 (1994)
26. K P Garrett et al., ibid. 92, 7172 (1995).
27. We thank R. Robinson of the Harvard Microchemistry Facility for peptide isolation. Supported by NIH grant GM41628 and by funds provided to the Oklahoma Medical Research Foundation by the H. A and Mary K. Chapman Charitable Trust (A.S , R.C.C , and J.W.C) and by the William K. Warren Foundation (K W J) AS is supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research.